Pulse Biosciences Inc
PLSE18.520USD
+2.250+13.83%
收盘 09/18, 16:00（美东）报价延迟15分钟
1.25B总市值
亏损市盈率 TTM
关于 Pulse Biosciences Inc 公司
Pulse Biosciences, Inc. 是一家生物电医学公司。该公司专有的 CellFX nsPFA 技术可将纳秒级电能脉冲传送至非热透明细胞，同时保护相邻的非细胞组织。该公司致力于开发 CellFX nsPFA 技术，用于治疗房颤和其他一些市场，这些市场可能会对患者和医疗服务提供者的医疗保健产生深远的积极影响。该公司的纳米脉冲刺激 (NPS) 技术是一种能量模式，可将纳秒级电能脉冲（每个脉冲长度不到百万分之一秒）传送至非热透明目标细胞，同时保护相邻的非细胞组织。该公司设计了各种施加器或末端执行器，以探索 CellFX 平台在治疗心脏病学、胃肠病学、妇科和耳鼻喉等其他医学专业疾病方面的潜在用途。
公司简介
公司代码PLSE
公司名称Pulse Biosciences Inc
上市日期May 18, 2016
CEOMr. Paul A. Laviolette
员工数量75
证券类型Ordinary Share
年结日May 18
公司地址3957 Point Eden Way
城市HAYWARD
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编94545
电话15109064600
网址https://www.pulsebiosciences.com/
公司代码PLSE
上市日期May 18, 2016
CEOMr. Paul A. Laviolette
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Robert William (Bob) Duggan
Mr. Robert William (Bob) Duggan
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
48.63M
+0.07%
Dr. Mahkam (Maky) Zanganeh
Dr. Mahkam (Maky) Zanganeh
Independent Director
Independent Director
873.47K
--
Mr. Darrin R. Uecker
Mr. Darrin R. Uecker
Chief Technology Officer, Director
Chief Technology Officer, Director
122.87K
--
Mr. Jon Skinner
Mr. Jon Skinner
Chief Financial Officer, Principal Financial Officer
Chief Financial Officer, Principal Financial Officer
--
--
Mr. Kevin P. Danahy
Mr. Kevin P. Danahy
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Mitchell E. Levinson
Mr. Mitchell E. Levinson
Chief Strategy Officer
Chief Strategy Officer
--
--
Mr. Paul A. Laviolette
Mr. Paul A. Laviolette
Co-Chairman of the Board, President, Chief Executive Officer
Co-Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Manmeet S. Soni, CPA
Mr. Manmeet S. Soni, CPA
Lead Independent Director
Lead Independent Director
--
--
Mr. Richard A. (Rich) van Den Broek
Mr. Richard A. (Rich) van Den Broek
Independent Director
Independent Director
--
--
Mr. Steven T. Weber
Mr. Steven T. Weber
Vice President of Accounting and Global Corporate Controller, Principal Accounting Officer
Vice President of Accounting and Global Corporate Controller, Principal Accounting Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Robert William (Bob) Duggan
Mr. Robert William (Bob) Duggan
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
48.63M
+0.07%
Dr. Mahkam (Maky) Zanganeh
Dr. Mahkam (Maky) Zanganeh
Independent Director
Independent Director
873.47K
--
Mr. Darrin R. Uecker
Mr. Darrin R. Uecker
Chief Technology Officer, Director
Chief Technology Officer, Director
122.87K
--
Mr. Jon Skinner
Mr. Jon Skinner
Chief Financial Officer, Principal Financial Officer
Chief Financial Officer, Principal Financial Officer
--
--
Mr. Kevin P. Danahy
Mr. Kevin P. Danahy
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Mitchell E. Levinson
Mr. Mitchell E. Levinson
Chief Strategy Officer
Chief Strategy Officer
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2020
FY2019
业务USD
名称
营收
占比
Systems
0.00
0.00%
Cycle units
0.00
0.00%
地区USD
名称
营收
占比
North America
0.00
0.00%
Rest of World
0.00
0.00%
业务
地区
业务USD
名称
营收
占比
Systems
0.00
0.00%
Cycle units
0.00
0.00%
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
Duggan (Robert William)
72.27%
The Vanguard Group, Inc.
1.81%
BlackRock Institutional Trust Company, N.A.
1.78%
Zanganeh (Mahkam)
1.30%
BofA Global Research (US)
1.16%
其他
21.68%
持股股东
持股股东
占比
Duggan (Robert William)
72.27%
The Vanguard Group, Inc.
1.81%
BlackRock Institutional Trust Company, N.A.
1.78%
Zanganeh (Mahkam)
1.30%
BofA Global Research (US)
1.16%
其他
21.68%
股东类型
持股股东
占比
Individual Investor
73.99%
Investment Advisor
4.96%
Investment Advisor/Hedge Fund
2.40%
Research Firm
1.31%
Hedge Fund
0.11%
Pension Fund
0.09%
Bank and Trust
0.08%
Venture Capital
0.05%
Sovereign Wealth Fund
0.03%
其他
16.98%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
170
55.62M
82.69%
-443.29K
2025Q1
171
55.60M
82.67%
-380.27K
2024Q4
161
55.79M
90.70%
+5.71M
2024Q3
153
49.96M
81.56%
+5.91M
2024Q2
136
43.75M
79.18%
-238.05K
2024Q1
135
43.68M
79.09%
-52.16K
2023Q4
133
43.32M
78.65%
+197.90K
2023Q3
133
41.46M
75.60%
-827.09K
2023Q2
134
41.10M
75.12%
+5.77M
2023Q1
139
24.09M
64.12%
-1.58M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Duggan (Robert William)
48.60M
72.24%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
839.06K
1.25%
-303.29K
-26.55%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.21M
1.81%
-25.91K
-2.09%
Mar 31, 2025
Zanganeh (Mahkam)
873.47K
1.3%
--
--
Mar 31, 2025
BofA Global Research (US)
777.76K
1.16%
-10.69K
-1.36%
Mar 31, 2025
Geode Capital Management, L.L.C.
465.72K
0.69%
+4.95K
+1.07%
Mar 31, 2025
State Street Global Advisors (US)
419.24K
0.62%
-55.01K
-11.60%
Mar 31, 2025
Griffin Asset Management, Inc.
233.56K
0.35%
-3.99K
-1.68%
Mar 31, 2025
Northern Trust Investments, Inc.
200.07K
0.3%
-8.66K
-4.15%
Mar 31, 2025
Charles Schwab Investment Management, Inc.
149.64K
0.22%
+433.00
+0.29%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
